Search Legislation

Commission Implementing Decision (EU) 2017/9Show full title

Commission Implementing Decision (EU) 2017/9 of 4 January 2017 authorising certain laboratories in Morocco and Taiwan to carry out serological tests to monitor the effectiveness of rabies vaccines in dogs, cats and ferrets (notified under document C(2016) 8803) (Text with EEA relevance)

 Help about what version

What Version

 Help about advanced features

Advanced Features

 Help about opening options

Opening Options

 Help about UK-EU Regulation

Legislation originating from the EU

When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.

Close

This item of legislation originated from the EU

Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).

Changes over time for: Commission Implementing Decision (EU) 2017/9

 Help about opening options

Status:

Point in time view as at 04/01/2017.

Changes to legislation:

There are currently no known outstanding effects by UK legislation for Commission Implementing Decision (EU) 2017/9. Help about Changes to Legislation

Close

Changes to Legislation

Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.

Commission Implementing Decision (EU) 2017/9

of 4 January 2017

authorising certain laboratories in Morocco and Taiwan to carry out serological tests to monitor the effectiveness of rabies vaccines in dogs, cats and ferrets

(notified under document C(2016) 8803)

(Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Council Decision 2000/258/EC of 20 March 2000 designating a specific institute responsible for establishing the criteria necessary for standardising the serological tests to monitor the effectiveness of rabies vaccines(1), and in particular Article 3(2) thereof,

Whereas:

(1) Decision 2000/258/EC designates the Agence française de sécurité sanitaire des aliments (AFSSA) in Nancy, France, as the specific institute responsible for establishing the criteria necessary for standardising the serological tests to monitor the effectiveness of rabies vaccines. The AFSSA has now been integrated into the Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail (ANSES) in France.

(2) Decision 2000/258/EC provides, inter alia, that the ANSES is to appraise laboratories in third countries that have applied for approval to carry out serological tests to monitor the effectiveness of rabies vaccines.

(3) The competent authority of Morocco has submitted an application for the approval of the laboratory ‘Service du Contrôle et des Expertises de l'Office National de Sécurité Sanitaire des Produits Alimentaires’ in Rabat, and the ANSES has established and submitted to the Commission a favourable appraisal report dated 19 October 2016 for this laboratory.

(4) The competent authority of Taiwan has submitted an application for the approval of the laboratories of the Epidemiology Research Division and the Biologics Division of the Animal Health Research Institute in New Taipei City, and the ANSES has established and submitted to the Commission a favourable appraisal report dated 19 October 2016 for those two laboratories.

(5) The laboratory ‘Service du Contrôle et des Expertises de l'Office National de Sécurité Sanitaire des Produits Alimentaires’ in Rabat and the laboratories of the Biologics Division and the Epidemiology Research Division of the Animal Health Research Institute in New Taipei City should therefore be authorised to carry out serological tests to monitor the effectiveness of rabies vaccines in dogs, cats and ferrets.

(6) The measures provided for in this Decision are in accordance with the opinion of Standing Committee on Plants, Animals, Food and Feed,

HAS ADOPTED THIS DECISION:

Article 1U.K.

In accordance with Article 3(2) of Decision 2000/258/EC, the following laboratories are hereby authorised to perform serological tests to monitor the effectiveness of rabies vaccines in dogs, cats and ferrets:

(a)

The laboratory ‘Service du Contrôle et des Expertises de l'Office National de Sécurité Sanitaire des Produits Alimentaires’

Direction de la Pharmacie et des Intrants Vétérinaires

Rue Ikhlass,

Cité Yacoub El Mansour,

BP 4509 Akkari

10120 Rabat

MOROCCO

(b)

Animal Health Research Institute

Biologics Division

No 376, Zhongzheng Rd, Tamsui District

New Taipei City 251

TAIWAN (R.O.C.)

(c)

Animal Health Research Institute

Epidemiology Research Division

No 376, Zhongzheng Rd, Tamsui District

New Taipei City 251

TAIWAN (R.O.C.)

Article 2U.K.

This Decision shall apply from 1 February 2017.

Article 3U.K.

This Decision is addressed to the Member States.

Done at Brussels, 4 January 2017.

For the Commission

Vytenis Andriukaitis

Member of the Commission

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.

Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.

Close

See additional information alongside the content

Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.

Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the EU Official Journal
  • lists of changes made by and/or affecting this legislation item
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Timeline of Changes

This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.

The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.

For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.

Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources